(Q40977570)

25 September 2017

title

Labetalol, a cross-over double blind controlled trial (English)

1 reference

8 April 2023

1 reference

8 April 2023

author name string

G. L. Sanders

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A365543

8 April 2023

P. A. Routledge

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A365543

8 April 2023

J. G. Rao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A365543

8 April 2023

G. M. Gales

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A365543

8 April 2023

D. M. Davies

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A365543

8 April 2023

M. D. Rawlins

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A365543

8 April 2023

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=365543

8 April 2023

publication date

1 December 1978

1 reference

25 September 2017

18 December 1978

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=365543

full work available at URL

8 April 2023

http://link.springer.com/content/pdf/10.1007/BF00611897.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF00611897/fulltext.html

8 April 2023

1 reference

http://link.springer.com/content/pdf/10.1007/BF00611897

8 April 2023

1 reference

European Journal of Clinical Pharmacology

8 April 2023

published in

1 reference

25 September 2017

volume

14

1 reference

25 September 2017

issue

5

1 reference

25 September 2017

page(s)

301-304

1 reference

https://scigraph.springernature.com/pub.10.1007/bf00611897

25 September 2017

exact match

0 references

cites work

Controlled comparison of labetalol and propranolol in the management of severe hypertension

1 reference

12 December 2020

Side Effects of Hypotensive Agents Evaluated by a Self-administered Questionnaire

1 reference

12 December 2020

Labetalol in long-term treatment of hypertension

1 reference

12 December 2020

Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine

1 reference

12 December 2020

Alpha and beta adrenergic blockade in hypertension.

1 reference

12 December 2020

Experience with labetalol in hypertension.

1 reference

12 December 2020

Double-blind trial of labetalol

1 reference

12 December 2020

Labetalol, a new alpha- and beta-adrenoreceptor blocking agent, in hypertension

1 reference

12 December 2020

Antinuclear antibodies in patients receiving non-practolol beta-blockers

1 reference

12 December 2020

A random-zero sphygmomanometer.

1 reference

12 December 2020

Alpha- and beta-adrenergic receptor blockade in the treatment of hypertension

1 reference

12 December 2020

Identifiers

DOI

10.1007/BF00611897

1 reference

25 September 2017

1 reference